News
Deliverable D7.2/3 Guidance and template for the interaction with patient representative, healthcare professional and other experts is now published.
EUnetHTA 21 is pleased to announce the publication of the deliverable D7.2/3. The objectives of this deliverable are to: More information can be found here: https://www.eunethta.eu/jointhtawork/ Many
Update on the EUnetHTA 21 public consultations on D6.2/3 Briefing Book Template and D6.4 Procedural Guidance JSC
Please note that the timeframe for the EUnetHTA 21 public consultations on D6.2/3 Briefing Book Template and D6.4 Procedural Guidance JSC has been updated. The
Deliverable D7.1 Guidance for the interaction between HTD and HTA is now published.
EUnetHTA 21 is pleased to announce the publication of the deliverable D7.1. This EUnetHTA 21 deliverable focusses on the guidance for the interaction between HTA bodies
Deliverable D4.4 on Endpoints is now published.
EUnetHTA 21 is pleased to announce the publication of the deliverable D4.4 on Endpoints. The objective of this deliverable was to develop a practical guideline on how to
EUnetHTA 21 announces publication of five deliverables
EUnetHTA 21 is pleased to announce the publication of five deliverables: D4.3.1 Practical guideline for direct and indirect comparisons, D4.5 Practical guideline on applicability of
[New] Patient input and healthcare professional input requested for second medical device Joint Clinical Assessment.
EUnetHTA 21 is pleased to announce it has started a second Joint Clinical Assessment on a medical device. The technology under assessment is a device
Patient input and healthcare professional input requested for first medical device Joint Clinical Assessment
EUnetHTA 21 is pleased to announce it has started a Joint Clinical Assessment on a medical device for male patients with urinary symptoms associated with
EUnetHTA 21-EMA Bilateral Meeting Minutes available now.
We are pleased to announce the publication of the EUnetHTA 21 – EMA bilateral meeting minutes. The joint meeting was held in June 2022. It
Updated documents for Joint Scientific Consultations (JSCs) now available.
The Guidance on Parallel EMA/EUnetHTA 21 JSC and the Briefing Book Template have been updated and are now available on the EUnetHTA 21 JSC website:
The 2nd Open Call for Joint Scientific Consultations (JSCs) closed and new products for the 2nd batch of parallel EMA/EUnetHTA 21 JSC have been selected
The EUnetHTA 21 2nd Open Call for applications from the pharmaceutical industry for Joint Scientific Consultations (JSCs) closed on 31 August, 2022. The EUnetHTA 21
